Publication: Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring
1
Issued Date
2017-04-01
Resource Type
ISSN
18767753
18735061
18735061
Other identifier(s)
2-s2.0-85015675981
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Stem Cell Research. Vol.20, (2017), 84-87
Suggested Citation
Wasinee Wongkummool, Warun Maneepitasut, Thongperm Munkongdee, Pirut Tong-ngam, Amornrat Tangprasittipap, Saovaros Svasti, Narisorn Kitiyanant, Kittiphong Paiboonsukwong, Suthat Fucharoen, Alisa Tubsuwan Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring. Stem Cell Research. Vol.20, (2017), 84-87. doi:10.1016/j.scr.2017.02.014 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/41931
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring
Other Contributor(s)
Abstract
© 2017 The Authors Hemoglobin Constant Spring (HbCS, HBA2: c.427T > C) is a common nondeletional α-thalassemia resulting from a nucleotide substitution at the termination codon of the HBA2 gene. Homozygosity for HbCS is characterized with mild anemia, jaundice, and splenomegaly. In this study, the human induced pluripotent stem cell line MUi017-A was successfully generated from peripheral blood CD34 + hematopoietic progenitors of a 52 year old female with homozygous HbCS. The MUi017-A cell line exhibited embryonic stem cell characteristics with consistent expression of specific pluripotency markers and the capability of differentiating into the three germ layers. The cell line may be used for the disease modeling.